334 - Validation of a Digital Pathology-Based Multimodal Artificial Intelligence Model in Oliogmetastatic Castration-Sensitive Prostate Cancer, including in Patients from the STOMP and ORIOLE Phase II Rando
Location: Room 207
Presenter: Philip Sutera, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
8:10 AM - 8:20 AM ET
333 - A Digital Pathology Multimodal Artificial Intelligence Algorithm is Associated with Pro-Metastatic Genomic Pathways in Oligometastatic Prostate Cancer
335 - A Validation Study on the Impact of Decipher® Testing on Treatment Recommendations in African American and Non-African American Men with Prostate Cancer (VANDAAM STUDY)
Location: Room 207
Presenter: Kosj Yamoah, MD, PhD – H. Lee Moffitt Cancer Center and Research Institute
8:30 AM - 8:40 AM ET
336 - Examination of Decipher Prostate Genomic Classifier in Patients with De Novo Metastatic Disease from a Large Scale Real-World Clinical and Transcriptomic Data Linkage
1109 - A Novel Comprehensive Multi-Omic Biosignature to Assess Recurrence Risk and Adjuvant Therapy Benefit in Early-Stage Hormone-Positive Invasive Breast Cancer Patients
1111 - Pre-Operative Boost Results in Low Rates of Re-Excision and Reduced Time from Initial Diagnosis to Completion of Local-Regional Treatment in Breast Cancer Patients
1119 - Normalization of Lactate Dehydrogenase (LDH) as a Potential Prognostic Factor for Relapsed/Refractory Aggressive B-Cell Lymphoma (R/R BCL) Patients Receiving CAR T Following Bridging Radiotherapy: Res
1113 - Applying GD-EOB-DTPA Enhanced MR to Unveil the Radiobiological Effect of Proton and Photon Therapy Based on the Longitudinal Evolution of the Focal Liver Reaction
1115 - Plan-Specific Range Tolerance Method for CBCT Triggered Adaptive Plans in Intensity Modulated Proton Therapy: Pilot Study on Head and Neck
Location: Room 147
Presenter: Weiguang Yao, PhD – University of Maryland School of Medicine, Baltimore
8:20 AM - 8:25 AM ET
1116 - Assessing Dose Uncertainties in Cardiac SBRT due to Cardiorespiratory Motion: Photon vs. Proton Therapy Comparison
Location: Room 147
Presenter: Guangjun Li, PhD – West China Hospital of Sichuan University
8:25 AM - 8:30 AM ET
1117 - A New RBE Optimization Method with Iterative Jacobian-Based Linearization for Carbon Ion Radiation Therapy
Location: Room 147
Presenter: Chao Wang, PhD – University of Kansas Medical Center
8:30 AM - 8:35 AM ET
1118 - Split Field IMPT Optimization to Maximize OAR Dose Rate and Implications for the Minimal FLASH Effect
Location: Room 147
Presenter: Ke Sheng, PhD – University of California, San Francisco
8:35 AM - 8:55 AM ET
Questions and Answers
Location: Room 147
8:55 AM - 9:00 AM ET
Closing
Location: Room 147
8:00 AM - 8:05 AM ET
Introduction
Location: Room 145
8:05 AM - 8:10 AM ET
1125 - Assessing the Feasibility and Dosimetric Impact of a Non-Animal Stabilized Hyaluronic Acid (NASHA) Rectal Spacer in High-Dose-Rate Brachytherapy for Prostate Cancer
Location: Room 145
Presenter: Reema Patel, BS – University of Virginia School of Medicine
8:10 AM - 8:15 AM ET
1126 - CT Dosimetry in Radioembolization: Image Acquisition Considerations
1129 - A Multi-Center Study on the Clinical Deliverability of Fully Automated Planning for Stereotactic Body Radiation Therapy in Lung Cancer Using a Deep Learning Transfer Method
1131 - Macropathology and Multimodal Magnetic Resonance Image Based Deep Learning Model for Personalized Definition of Target Volume in Patients with Glioma
1135 - Analysis of Late Cognitive Outcomes after Whole Brain Radiotherapy and Radiosurgery for Brain Metastases in the North Central Cancer Treatment Group (NCCTG) N0574 and N107C Clinical Trials
352 - The Effect of Tumor Biological Effective Dose (BED) on Stereotactic Body Radiotherapy (SBRT) Outcomes for Locally Advanced Cholangiocarcinoma (CCA): An Analysis of the ABC-07 Randomized Trial
353 - Safety and Efficacy Results of a Phase II Clinical Trial Evaluating Moderately-Hypofractionated Chemoradiotherapy for Pancreatic Ductal Adenocarcinoma
1144 - Development of Prediction Model for Right and Left Liver Hypertrophy to Estimate Response in Patients Treatments Simulated with Photon Based 3DCRT and IMRT Plans
1148 - General and Organ Specific Consensus Recommendations for Stereotactic Body Radiotherapy Dose Prescription according to ICRU Report 91 from Working Groups on Stereotactic Radiotherapy
1158 - Optimizing Target and Diaphragmatic Configuration, and Dosimetric Benefits Using Continuous Positive Airway Pressure (CPAP) in Stereotactic Ablative Radiotherapy for Lung Tumors
Location: Room 143
Presenter: Jung Bin Park, MD – Seoul National University College of Medicine
12:55 PM - 1:00 PM ET
1159 - Addressing the Impact of Skin Pigmentation on Quantitative Cherenkov Dosimetry in the First Diverse Patient Imaging Study
1160 - Efficacy of Thermoplastic Mask Heating before Radiotherapy in Reducing Setup Error for Patients with Gynecological Tumor: A Randomized Controlled Study